Microbiology & Infectious Diseases

Sepsis poses a substantial public health challenge, affecting approximately 3.4 million individuals and causing 700,000 deaths every year…

Evidence has revealed how environmental bacteria have adapted to live inside humans as the oral microbiome…

Research has demonstrated the potential of using a fungal vaccine to improve immune response to infections…

EMERGING research has identified a correlation between the presence of a specific bacteria in the gut microbiome and colon cancer…

Although the direct association between nasal microbiota and COVID-19 severity remains unclear, this study has revealed…

Researchers from the molecular biology department at The Pennsylvania State University, USA, have come up with an innovative strategy of using a non-functioning synthetic version of SARS-CoV-2 to annihilate the disease-causing alternative. This synthetic version of the COVID-19 virus has been proven to interfere with the growth process of the SARS-CoV-2 virus and could be developed as anti-viral therapy for the disease.

The biomarkers found during the interruption of ART could help predict HIV remission by providing interpretative clues on the biological mechanisms of HIV duplication after stopping ART, as well as assist in the design of a new way to cure the disease.

mRNA coronavirus disease (COVID-19) vaccines are highly effective at producing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant and lactating women, a new study, the largest of its kind to date, has reported.